"In this phase 2b, multicenter, randomized, double-blind, placebo-controlled study of 4 dose levels of MM120 that included 198 adults with generalized anxiety disorder, the primary outcome of a dose-response relationship for change in Hamilton Anxiety Rating Scale score at week 4 was statistically significant."